Relationship Between Modality-specific Dual-task Performance and Immersive Exergaming Outcomes in Healthy Athletes (DUTACO)

August 27, 2026 updated by: Michelle C. Haas, Zurich University of Applied Sciences

The goal of this clinical trial is to provide a more specific understanding of which dual task conditions elicit changes in either motor or cognitive performance. A dual-task is a simultaneously performed motor and cognitive task. Exergaming describes physically active gaming. The main questions the study aims to answer are:

  • Can performance in visual and auditory dual-task paradigms explain performance in an immersive exergaming task in healthy athletes?
  • How are exergaming scores associated with athletic performance tests?
  • What biomechanical movement patterns are shown during dual-tasks? Researchers will also compare performance of those experienced with jumping and those inexperienced with jumping.

Participants will:

  • Complete two sessions performing athletic performance tests, cognitive tasks, and different dual-tasks while their movement pattern is recorded
  • Complete questionnaires on load, stress, and sleep during the sessions

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The two sessions last each approximately 2 hours and take place within one to 12 weeks. Both sessions involve measurement of biomechanical movement patterns with motion capture.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
61

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Switzerland
    • Canton of Zurich
      • Winterthur, Canton of Zurich, Switzerland, 8400
        • ZHAW Zurich University of Applied Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • age between 18 and 34 years
  • self-reported recreationally or competitively active (more than 2 hours per week)
  • self-reported ability to complete change of direction, balancing, and jumping tasks
  • capacity to sign informed consent
  • ability to understand German

Exclusion Criteria:

  • acute injury in the last 6 months resulting in missing more than 3 training sessions
  • severe comorbidity or condition which would prohibit performance of the lsted testing tasks
  • self-reported pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Dual-Task paradigms
All participants are exposed to the same dual-task paradigms described in the intervention.
Other: different dual-task paradigms
Participants will perform combined motor-cognitive tasks. During the first session balancing and bilateral jumping will be combined with an additional auditory or visual cognitive task. During the second session participants will do a combined motor-cognitive task in exergaming.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Cognitive dual-task cost
Time Frame: Measurement session 1 (day 0) and session 2 (days 6-90)
Dual-task cost with the different modalities are operationalized by reaction time.
Measurement session 1 (day 0) and session 2 (days 6-90)
Exergaming performance
Time Frame: Session 2 (days 6-90)
Operationalized as task success rate
Session 2 (days 6-90)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Motor dual-task cost
Time Frame: Session 1 (day 0)
The motor dual-task costs are operationalized by the peak knee abduction angle.
Session 1 (day 0)
Countermovement Jump
Time Frame: Session 1 (day 0) and session 2 (day 6-90)
Height of a countermovement jump
Session 1 (day 0) and session 2 (day 6-90)
ProAgility Test
Time Frame: Session 1 (day 0) and session 2 (day 6-90)
Measured using the total elapsed time in the ProAgility Test.
Session 1 (day 0) and session 2 (day 6-90)
Y-Balance Test
Time Frame: Session 1 (day 0) and session 2 (days 6-90)
Measured using the composite reach distance in all directions of the Y-Balance Test.
Session 1 (day 0) and session 2 (days 6-90)
Joint Angle
Time Frame: Session 1 (day 0) and session 2 (day 6-90)
Angles of ankle, knee, and hip during the dual-tasks.
Session 1 (day 0) and session 2 (day 6-90)
Joint Moment
Time Frame: Session 1 (day 0) and session 2 (day 6-90)
Moments of ankle, knee, and hip during the dual-tasks.
Session 1 (day 0) and session 2 (day 6-90)
Ground Reaction Force
Time Frame: Session 1 (day 0) and session 2 (day 6-90)
Ground reaction force during the dual-tasks.
Session 1 (day 0) and session 2 (day 6-90)
Center of pressure
Time Frame: Session 1 (day 0) and session 2 (day 6-90)
Center of pressure during the dual-tasks.
Session 1 (day 0) and session 2 (day 6-90)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Zurich University of Applied Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
March 24, 2026

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 20, 2026

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
August 27, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 26, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 4, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 10, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 1, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 27, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • DUTACO

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Pooled data of participants will be shared on a repository if consent is given by the participants.

IPD Sharing Time Frame

Within one year after completion of the study.

IPD Sharing Access Criteria

The access conditions will be defined in the license statement adjacent to the dataset.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings